PHYTOMEDICINE-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2205178, encodeId=ab7122051e892, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：中药单体;药理学 经验分享：最近看了几篇文章：文章1: 收稿2024.1.20；修改2024.5.5；接受2024.5.15 文章2: 收稿2023.11.9；修改2024.3.12；接受2024.4.22 文章3: 收稿2023.6.29；修改2023.12.28；接受2024.5.7, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f3b21498451, createdName=suguoqing.my265, createdTime=Fri May 17 13:28:46 CST 2024, time=3小时前, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2201420, encodeId=0ec7220142068, content=状态一直停留在submitted to the journal 9天了，😭😭😭，正常吗难道五一也放假了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07092326647, createdName=1225f99em69(暂无昵称), createdTime=Thu May 02 07:34:49 CST 2024, time=2024-05-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2168450, encodeId=9f872168450a0, content=偏重的研究方向：中药单体;心血管 经验分享：请问submitted状态要持续多久啊？我的已经2周没变过了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2fba8367429, createdName=ms7000001909487480, createdTime=Tue Nov 14 13:52:58 CST 2023, time=2023-11-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2193985, encodeId=ad53219398535, content=审稿速度:24.0 | 投稿命中率:50.0 经验分享：慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15626507481, createdName=ms5000002039979243, createdTime=Tue Mar 19 06:01:55 CST 2024, time=2024-03-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2202286, encodeId=2f792202286ea, content=偏重的研究方向：药理学;心血管 经验分享：请问submit to journal到with editor这一步大家都等了多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Tue May 07 19:50:26 CST 2024, time=2024-05-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2204971, encodeId=3bb322049e1fc, content=偏重的研究方向：中药单体 经验分享：请问换编辑后with editor assessment要多久才能under review，已经十多天了😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07092326647, createdName=1225f99em69(暂无昵称), createdTime=Thu May 16 08:42:57 CST 2024, time=昨天, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2204848, encodeId=10d622048481d, content=偏重的研究方向：中药复方 经验分享：投了一个星期了，还是submitted to journal，这正常吗家人们, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=468e9243712, createdName=ms8000002041881019, createdTime=Wed May 15 16:47:57 CST 2024, time=2024-05-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2198942, encodeId=0763219894231, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肾脏病;中药复方 经验分享：返修回去一个多月了，还是在邀请审稿人，难受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f22a5486325, createdName=ms8000001467150727, createdTime=Wed Apr 17 12:43:58 CST 2024, time=2024-04-17, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2202273, encodeId=5d2522022e3b9, content=大家submit to journal之后多久会变成with editor啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Tue May 07 19:27:24 CST 2024, time=2024-05-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2204597, encodeId=bac4220459ece, content=大家有遇到过一审换编辑的情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Tue May 14 10:59:31 CST 2024, time=2024-05-14, status=1, ipAttribution=北京)]

3小时前 suguoqing.my265 来自吉林省

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：中药单体;药理学
经验分享：最近看了几篇文章：文章1: 收稿2024.1.20；修改2024.5.5；接受2024.5.15 文章2: 收稿2023.11.9；修改2024.3.12；接受2024.4.22 文章3: 收稿2023.6.29；修改2023.12.28；接受2024.5.7

0 0

[GetPortalCommentsPageByObjectIdResponse(id=2205178, encodeId=ab7122051e892, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：中药单体;药理学 经验分享：最近看了几篇文章：文章1: 收稿2024.1.20；修改2024.5.5；接受2024.5.15 文章2: 收稿2023.11.9；修改2024.3.12；接受2024.4.22 文章3: 收稿2023.6.29；修改2023.12.28；接受2024.5.7, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f3b21498451, createdName=suguoqing.my265, createdTime=Fri May 17 13:28:46 CST 2024, time=3小时前, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2201420, encodeId=0ec7220142068, content=状态一直停留在submitted to the journal 9天了，😭😭😭，正常吗难道五一也放假了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07092326647, createdName=1225f99em69(暂无昵称), createdTime=Thu May 02 07:34:49 CST 2024, time=2024-05-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2168450, encodeId=9f872168450a0, content=偏重的研究方向：中药单体;心血管 经验分享：请问submitted状态要持续多久啊？我的已经2周没变过了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2fba8367429, createdName=ms7000001909487480, createdTime=Tue Nov 14 13:52:58 CST 2023, time=2023-11-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2193985, encodeId=ad53219398535, content=审稿速度:24.0 | 投稿命中率:50.0 经验分享：慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15626507481, createdName=ms5000002039979243, createdTime=Tue Mar 19 06:01:55 CST 2024, time=2024-03-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2202286, encodeId=2f792202286ea, content=偏重的研究方向：药理学;心血管 经验分享：请问submit to journal到with editor这一步大家都等了多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Tue May 07 19:50:26 CST 2024, time=2024-05-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2204971, encodeId=3bb322049e1fc, content=偏重的研究方向：中药单体 经验分享：请问换编辑后with editor assessment要多久才能under review，已经十多天了😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07092326647, createdName=1225f99em69(暂无昵称), createdTime=Thu May 16 08:42:57 CST 2024, time=昨天, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2204848, encodeId=10d622048481d, content=偏重的研究方向：中药复方 经验分享：投了一个星期了，还是submitted to journal，这正常吗家人们, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=468e9243712, createdName=ms8000002041881019, createdTime=Wed May 15 16:47:57 CST 2024, time=2024-05-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2198942, encodeId=0763219894231, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肾脏病;中药复方 经验分享：返修回去一个多月了，还是在邀请审稿人，难受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f22a5486325, createdName=ms8000001467150727, createdTime=Wed Apr 17 12:43:58 CST 2024, time=2024-04-17, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2202273, encodeId=5d2522022e3b9, content=大家submit to journal之后多久会变成with editor啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Tue May 07 19:27:24 CST 2024, time=2024-05-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2204597, encodeId=bac4220459ece, content=大家有遇到过一审换编辑的情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Tue May 14 10:59:31 CST 2024, time=2024-05-14, status=1, ipAttribution=北京)]

2024-05-02 1225f99em69(暂无昵称) 来自北京

状态一直停留在submitted to the journal 9天了，😭😭😭，正常吗难道五一也放假了？

11 10

展开10条回复

[GetPortalCommentsPageByObjectIdResponse(id=2205178, encodeId=ab7122051e892, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：中药单体;药理学 经验分享：最近看了几篇文章：文章1: 收稿2024.1.20；修改2024.5.5；接受2024.5.15 文章2: 收稿2023.11.9；修改2024.3.12；接受2024.4.22 文章3: 收稿2023.6.29；修改2023.12.28；接受2024.5.7, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f3b21498451, createdName=suguoqing.my265, createdTime=Fri May 17 13:28:46 CST 2024, time=3小时前, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2201420, encodeId=0ec7220142068, content=状态一直停留在submitted to the journal 9天了，😭😭😭，正常吗难道五一也放假了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07092326647, createdName=1225f99em69(暂无昵称), createdTime=Thu May 02 07:34:49 CST 2024, time=2024-05-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2168450, encodeId=9f872168450a0, content=偏重的研究方向：中药单体;心血管 经验分享：请问submitted状态要持续多久啊？我的已经2周没变过了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2fba8367429, createdName=ms7000001909487480, createdTime=Tue Nov 14 13:52:58 CST 2023, time=2023-11-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2193985, encodeId=ad53219398535, content=审稿速度:24.0 | 投稿命中率:50.0 经验分享：慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15626507481, createdName=ms5000002039979243, createdTime=Tue Mar 19 06:01:55 CST 2024, time=2024-03-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2202286, encodeId=2f792202286ea, content=偏重的研究方向：药理学;心血管 经验分享：请问submit to journal到with editor这一步大家都等了多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Tue May 07 19:50:26 CST 2024, time=2024-05-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2204971, encodeId=3bb322049e1fc, content=偏重的研究方向：中药单体 经验分享：请问换编辑后with editor assessment要多久才能under review，已经十多天了😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07092326647, createdName=1225f99em69(暂无昵称), createdTime=Thu May 16 08:42:57 CST 2024, time=昨天, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2204848, encodeId=10d622048481d, content=偏重的研究方向：中药复方 经验分享：投了一个星期了，还是submitted to journal，这正常吗家人们, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=468e9243712, createdName=ms8000002041881019, createdTime=Wed May 15 16:47:57 CST 2024, time=2024-05-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2198942, encodeId=0763219894231, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肾脏病;中药复方 经验分享：返修回去一个多月了，还是在邀请审稿人，难受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f22a5486325, createdName=ms8000001467150727, createdTime=Wed Apr 17 12:43:58 CST 2024, time=2024-04-17, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2202273, encodeId=5d2522022e3b9, content=大家submit to journal之后多久会变成with editor啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Tue May 07 19:27:24 CST 2024, time=2024-05-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2204597, encodeId=bac4220459ece, content=大家有遇到过一审换编辑的情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Tue May 14 10:59:31 CST 2024, time=2024-05-14, status=1, ipAttribution=北京)]

2023-11-14 ms7000001909487480 来自北京

偏重的研究方向：中药单体;心血管
经验分享：请问submitted状态要持续多久啊？我的已经2周没变过了。

30 18

展开18条回复

[GetPortalCommentsPageByObjectIdResponse(id=2205178, encodeId=ab7122051e892, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：中药单体;药理学 经验分享：最近看了几篇文章：文章1: 收稿2024.1.20；修改2024.5.5；接受2024.5.15 文章2: 收稿2023.11.9；修改2024.3.12；接受2024.4.22 文章3: 收稿2023.6.29；修改2023.12.28；接受2024.5.7, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f3b21498451, createdName=suguoqing.my265, createdTime=Fri May 17 13:28:46 CST 2024, time=3小时前, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2201420, encodeId=0ec7220142068, content=状态一直停留在submitted to the journal 9天了，😭😭😭，正常吗难道五一也放假了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07092326647, createdName=1225f99em69(暂无昵称), createdTime=Thu May 02 07:34:49 CST 2024, time=2024-05-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2168450, encodeId=9f872168450a0, content=偏重的研究方向：中药单体;心血管 经验分享：请问submitted状态要持续多久啊？我的已经2周没变过了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2fba8367429, createdName=ms7000001909487480, createdTime=Tue Nov 14 13:52:58 CST 2023, time=2023-11-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2193985, encodeId=ad53219398535, content=审稿速度:24.0 | 投稿命中率:50.0 经验分享：慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15626507481, createdName=ms5000002039979243, createdTime=Tue Mar 19 06:01:55 CST 2024, time=2024-03-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2202286, encodeId=2f792202286ea, content=偏重的研究方向：药理学;心血管 经验分享：请问submit to journal到with editor这一步大家都等了多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Tue May 07 19:50:26 CST 2024, time=2024-05-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2204971, encodeId=3bb322049e1fc, content=偏重的研究方向：中药单体 经验分享：请问换编辑后with editor assessment要多久才能under review，已经十多天了😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07092326647, createdName=1225f99em69(暂无昵称), createdTime=Thu May 16 08:42:57 CST 2024, time=昨天, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2204848, encodeId=10d622048481d, content=偏重的研究方向：中药复方 经验分享：投了一个星期了，还是submitted to journal，这正常吗家人们, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=468e9243712, createdName=ms8000002041881019, createdTime=Wed May 15 16:47:57 CST 2024, time=2024-05-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2198942, encodeId=0763219894231, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肾脏病;中药复方 经验分享：返修回去一个多月了，还是在邀请审稿人，难受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f22a5486325, createdName=ms8000001467150727, createdTime=Wed Apr 17 12:43:58 CST 2024, time=2024-04-17, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2202273, encodeId=5d2522022e3b9, content=大家submit to journal之后多久会变成with editor啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Tue May 07 19:27:24 CST 2024, time=2024-05-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2204597, encodeId=bac4220459ece, content=大家有遇到过一审换编辑的情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Tue May 14 10:59:31 CST 2024, time=2024-05-14, status=1, ipAttribution=北京)]

2024-03-19 ms5000002039979243 来自北京

审稿速度:24.0 | 投稿命中率:50.0
经验分享：慢

12 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2205178, encodeId=ab7122051e892, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：中药单体;药理学 经验分享：最近看了几篇文章：文章1: 收稿2024.1.20；修改2024.5.5；接受2024.5.15 文章2: 收稿2023.11.9；修改2024.3.12；接受2024.4.22 文章3: 收稿2023.6.29；修改2023.12.28；接受2024.5.7, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f3b21498451, createdName=suguoqing.my265, createdTime=Fri May 17 13:28:46 CST 2024, time=3小时前, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2201420, encodeId=0ec7220142068, content=状态一直停留在submitted to the journal 9天了，😭😭😭，正常吗难道五一也放假了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07092326647, createdName=1225f99em69(暂无昵称), createdTime=Thu May 02 07:34:49 CST 2024, time=2024-05-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2168450, encodeId=9f872168450a0, content=偏重的研究方向：中药单体;心血管 经验分享：请问submitted状态要持续多久啊？我的已经2周没变过了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2fba8367429, createdName=ms7000001909487480, createdTime=Tue Nov 14 13:52:58 CST 2023, time=2023-11-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2193985, encodeId=ad53219398535, content=审稿速度:24.0 | 投稿命中率:50.0 经验分享：慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15626507481, createdName=ms5000002039979243, createdTime=Tue Mar 19 06:01:55 CST 2024, time=2024-03-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2202286, encodeId=2f792202286ea, content=偏重的研究方向：药理学;心血管 经验分享：请问submit to journal到with editor这一步大家都等了多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Tue May 07 19:50:26 CST 2024, time=2024-05-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2204971, encodeId=3bb322049e1fc, content=偏重的研究方向：中药单体 经验分享：请问换编辑后with editor assessment要多久才能under review，已经十多天了😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07092326647, createdName=1225f99em69(暂无昵称), createdTime=Thu May 16 08:42:57 CST 2024, time=昨天, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2204848, encodeId=10d622048481d, content=偏重的研究方向：中药复方 经验分享：投了一个星期了，还是submitted to journal，这正常吗家人们, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=468e9243712, createdName=ms8000002041881019, createdTime=Wed May 15 16:47:57 CST 2024, time=2024-05-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2198942, encodeId=0763219894231, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肾脏病;中药复方 经验分享：返修回去一个多月了，还是在邀请审稿人，难受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f22a5486325, createdName=ms8000001467150727, createdTime=Wed Apr 17 12:43:58 CST 2024, time=2024-04-17, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2202273, encodeId=5d2522022e3b9, content=大家submit to journal之后多久会变成with editor啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Tue May 07 19:27:24 CST 2024, time=2024-05-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2204597, encodeId=bac4220459ece, content=大家有遇到过一审换编辑的情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Tue May 14 10:59:31 CST 2024, time=2024-05-14, status=1, ipAttribution=北京)]

2024-05-07 ms8000001555903844 来自北京

偏重的研究方向：药理学;心血管
经验分享：请问submit to journal到with editor这一步大家都等了多久啊

3 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2205178, encodeId=ab7122051e892, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：中药单体;药理学 经验分享：最近看了几篇文章：文章1: 收稿2024.1.20；修改2024.5.5；接受2024.5.15 文章2: 收稿2023.11.9；修改2024.3.12；接受2024.4.22 文章3: 收稿2023.6.29；修改2023.12.28；接受2024.5.7, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f3b21498451, createdName=suguoqing.my265, createdTime=Fri May 17 13:28:46 CST 2024, time=3小时前, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2201420, encodeId=0ec7220142068, content=状态一直停留在submitted to the journal 9天了，😭😭😭，正常吗难道五一也放假了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07092326647, createdName=1225f99em69(暂无昵称), createdTime=Thu May 02 07:34:49 CST 2024, time=2024-05-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2168450, encodeId=9f872168450a0, content=偏重的研究方向：中药单体;心血管 经验分享：请问submitted状态要持续多久啊？我的已经2周没变过了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2fba8367429, createdName=ms7000001909487480, createdTime=Tue Nov 14 13:52:58 CST 2023, time=2023-11-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2193985, encodeId=ad53219398535, content=审稿速度:24.0 | 投稿命中率:50.0 经验分享：慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15626507481, createdName=ms5000002039979243, createdTime=Tue Mar 19 06:01:55 CST 2024, time=2024-03-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2202286, encodeId=2f792202286ea, content=偏重的研究方向：药理学;心血管 经验分享：请问submit to journal到with editor这一步大家都等了多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Tue May 07 19:50:26 CST 2024, time=2024-05-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2204971, encodeId=3bb322049e1fc, content=偏重的研究方向：中药单体 经验分享：请问换编辑后with editor assessment要多久才能under review，已经十多天了😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07092326647, createdName=1225f99em69(暂无昵称), createdTime=Thu May 16 08:42:57 CST 2024, time=昨天, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2204848, encodeId=10d622048481d, content=偏重的研究方向：中药复方 经验分享：投了一个星期了，还是submitted to journal，这正常吗家人们, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=468e9243712, createdName=ms8000002041881019, createdTime=Wed May 15 16:47:57 CST 2024, time=2024-05-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2198942, encodeId=0763219894231, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肾脏病;中药复方 经验分享：返修回去一个多月了，还是在邀请审稿人，难受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f22a5486325, createdName=ms8000001467150727, createdTime=Wed Apr 17 12:43:58 CST 2024, time=2024-04-17, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2202273, encodeId=5d2522022e3b9, content=大家submit to journal之后多久会变成with editor啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Tue May 07 19:27:24 CST 2024, time=2024-05-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2204597, encodeId=bac4220459ece, content=大家有遇到过一审换编辑的情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Tue May 14 10:59:31 CST 2024, time=2024-05-14, status=1, ipAttribution=北京)]

昨天 1225f99em69(暂无昵称) 来自江西省

偏重的研究方向：中药单体
经验分享：请问换编辑后with editor assessment要多久才能under review，已经十多天了😂

2 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2205178, encodeId=ab7122051e892, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：中药单体;药理学 经验分享：最近看了几篇文章：文章1: 收稿2024.1.20；修改2024.5.5；接受2024.5.15 文章2: 收稿2023.11.9；修改2024.3.12；接受2024.4.22 文章3: 收稿2023.6.29；修改2023.12.28；接受2024.5.7, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f3b21498451, createdName=suguoqing.my265, createdTime=Fri May 17 13:28:46 CST 2024, time=3小时前, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2201420, encodeId=0ec7220142068, content=状态一直停留在submitted to the journal 9天了，😭😭😭，正常吗难道五一也放假了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07092326647, createdName=1225f99em69(暂无昵称), createdTime=Thu May 02 07:34:49 CST 2024, time=2024-05-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2168450, encodeId=9f872168450a0, content=偏重的研究方向：中药单体;心血管 经验分享：请问submitted状态要持续多久啊？我的已经2周没变过了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2fba8367429, createdName=ms7000001909487480, createdTime=Tue Nov 14 13:52:58 CST 2023, time=2023-11-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2193985, encodeId=ad53219398535, content=审稿速度:24.0 | 投稿命中率:50.0 经验分享：慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15626507481, createdName=ms5000002039979243, createdTime=Tue Mar 19 06:01:55 CST 2024, time=2024-03-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2202286, encodeId=2f792202286ea, content=偏重的研究方向：药理学;心血管 经验分享：请问submit to journal到with editor这一步大家都等了多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Tue May 07 19:50:26 CST 2024, time=2024-05-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2204971, encodeId=3bb322049e1fc, content=偏重的研究方向：中药单体 经验分享：请问换编辑后with editor assessment要多久才能under review，已经十多天了😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07092326647, createdName=1225f99em69(暂无昵称), createdTime=Thu May 16 08:42:57 CST 2024, time=昨天, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2204848, encodeId=10d622048481d, content=偏重的研究方向：中药复方 经验分享：投了一个星期了，还是submitted to journal，这正常吗家人们, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=468e9243712, createdName=ms8000002041881019, createdTime=Wed May 15 16:47:57 CST 2024, time=2024-05-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2198942, encodeId=0763219894231, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肾脏病;中药复方 经验分享：返修回去一个多月了，还是在邀请审稿人，难受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f22a5486325, createdName=ms8000001467150727, createdTime=Wed Apr 17 12:43:58 CST 2024, time=2024-04-17, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2202273, encodeId=5d2522022e3b9, content=大家submit to journal之后多久会变成with editor啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Tue May 07 19:27:24 CST 2024, time=2024-05-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2204597, encodeId=bac4220459ece, content=大家有遇到过一审换编辑的情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Tue May 14 10:59:31 CST 2024, time=2024-05-14, status=1, ipAttribution=北京)]

2024-05-15 ms8000002041881019 来自北京

偏重的研究方向：中药复方
经验分享：投了一个星期了，还是submitted to journal，这正常吗家人们

1 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2205178, encodeId=ab7122051e892, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：中药单体;药理学 经验分享：最近看了几篇文章：文章1: 收稿2024.1.20；修改2024.5.5；接受2024.5.15 文章2: 收稿2023.11.9；修改2024.3.12；接受2024.4.22 文章3: 收稿2023.6.29；修改2023.12.28；接受2024.5.7, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f3b21498451, createdName=suguoqing.my265, createdTime=Fri May 17 13:28:46 CST 2024, time=3小时前, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2201420, encodeId=0ec7220142068, content=状态一直停留在submitted to the journal 9天了，😭😭😭，正常吗难道五一也放假了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07092326647, createdName=1225f99em69(暂无昵称), createdTime=Thu May 02 07:34:49 CST 2024, time=2024-05-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2168450, encodeId=9f872168450a0, content=偏重的研究方向：中药单体;心血管 经验分享：请问submitted状态要持续多久啊？我的已经2周没变过了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2fba8367429, createdName=ms7000001909487480, createdTime=Tue Nov 14 13:52:58 CST 2023, time=2023-11-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2193985, encodeId=ad53219398535, content=审稿速度:24.0 | 投稿命中率:50.0 经验分享：慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15626507481, createdName=ms5000002039979243, createdTime=Tue Mar 19 06:01:55 CST 2024, time=2024-03-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2202286, encodeId=2f792202286ea, content=偏重的研究方向：药理学;心血管 经验分享：请问submit to journal到with editor这一步大家都等了多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Tue May 07 19:50:26 CST 2024, time=2024-05-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2204971, encodeId=3bb322049e1fc, content=偏重的研究方向：中药单体 经验分享：请问换编辑后with editor assessment要多久才能under review，已经十多天了😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07092326647, createdName=1225f99em69(暂无昵称), createdTime=Thu May 16 08:42:57 CST 2024, time=昨天, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2204848, encodeId=10d622048481d, content=偏重的研究方向：中药复方 经验分享：投了一个星期了，还是submitted to journal，这正常吗家人们, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=468e9243712, createdName=ms8000002041881019, createdTime=Wed May 15 16:47:57 CST 2024, time=2024-05-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2198942, encodeId=0763219894231, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肾脏病;中药复方 经验分享：返修回去一个多月了，还是在邀请审稿人，难受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f22a5486325, createdName=ms8000001467150727, createdTime=Wed Apr 17 12:43:58 CST 2024, time=2024-04-17, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2202273, encodeId=5d2522022e3b9, content=大家submit to journal之后多久会变成with editor啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Tue May 07 19:27:24 CST 2024, time=2024-05-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2204597, encodeId=bac4220459ece, content=大家有遇到过一审换编辑的情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Tue May 14 10:59:31 CST 2024, time=2024-05-14, status=1, ipAttribution=北京)]

2024-04-17 ms8000001467150727 来自北京

审稿速度:12.0 | 投稿命中率:50.0
偏重的研究方向：肾脏病;中药复方
经验分享：返修回去一个多月了，还是在邀请审稿人，难受

1 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2205178, encodeId=ab7122051e892, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：中药单体;药理学 经验分享：最近看了几篇文章：文章1: 收稿2024.1.20；修改2024.5.5；接受2024.5.15 文章2: 收稿2023.11.9；修改2024.3.12；接受2024.4.22 文章3: 收稿2023.6.29；修改2023.12.28；接受2024.5.7, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f3b21498451, createdName=suguoqing.my265, createdTime=Fri May 17 13:28:46 CST 2024, time=3小时前, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2201420, encodeId=0ec7220142068, content=状态一直停留在submitted to the journal 9天了，😭😭😭，正常吗难道五一也放假了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07092326647, createdName=1225f99em69(暂无昵称), createdTime=Thu May 02 07:34:49 CST 2024, time=2024-05-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2168450, encodeId=9f872168450a0, content=偏重的研究方向：中药单体;心血管 经验分享：请问submitted状态要持续多久啊？我的已经2周没变过了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2fba8367429, createdName=ms7000001909487480, createdTime=Tue Nov 14 13:52:58 CST 2023, time=2023-11-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2193985, encodeId=ad53219398535, content=审稿速度:24.0 | 投稿命中率:50.0 经验分享：慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15626507481, createdName=ms5000002039979243, createdTime=Tue Mar 19 06:01:55 CST 2024, time=2024-03-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2202286, encodeId=2f792202286ea, content=偏重的研究方向：药理学;心血管 经验分享：请问submit to journal到with editor这一步大家都等了多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Tue May 07 19:50:26 CST 2024, time=2024-05-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2204971, encodeId=3bb322049e1fc, content=偏重的研究方向：中药单体 经验分享：请问换编辑后with editor assessment要多久才能under review，已经十多天了😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07092326647, createdName=1225f99em69(暂无昵称), createdTime=Thu May 16 08:42:57 CST 2024, time=昨天, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2204848, encodeId=10d622048481d, content=偏重的研究方向：中药复方 经验分享：投了一个星期了，还是submitted to journal，这正常吗家人们, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=468e9243712, createdName=ms8000002041881019, createdTime=Wed May 15 16:47:57 CST 2024, time=2024-05-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2198942, encodeId=0763219894231, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肾脏病;中药复方 经验分享：返修回去一个多月了，还是在邀请审稿人，难受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f22a5486325, createdName=ms8000001467150727, createdTime=Wed Apr 17 12:43:58 CST 2024, time=2024-04-17, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2202273, encodeId=5d2522022e3b9, content=大家submit to journal之后多久会变成with editor啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Tue May 07 19:27:24 CST 2024, time=2024-05-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2204597, encodeId=bac4220459ece, content=大家有遇到过一审换编辑的情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Tue May 14 10:59:31 CST 2024, time=2024-05-14, status=1, ipAttribution=北京)]

2024-05-07 ms8000001555903844 来自北京

大家submit to journal之后多久会变成with editor啊？

4 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2205178, encodeId=ab7122051e892, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：中药单体;药理学 经验分享：最近看了几篇文章：文章1: 收稿2024.1.20；修改2024.5.5；接受2024.5.15 文章2: 收稿2023.11.9；修改2024.3.12；接受2024.4.22 文章3: 收稿2023.6.29；修改2023.12.28；接受2024.5.7, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f3b21498451, createdName=suguoqing.my265, createdTime=Fri May 17 13:28:46 CST 2024, time=3小时前, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2201420, encodeId=0ec7220142068, content=状态一直停留在submitted to the journal 9天了，😭😭😭，正常吗难道五一也放假了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07092326647, createdName=1225f99em69(暂无昵称), createdTime=Thu May 02 07:34:49 CST 2024, time=2024-05-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2168450, encodeId=9f872168450a0, content=偏重的研究方向：中药单体;心血管 经验分享：请问submitted状态要持续多久啊？我的已经2周没变过了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2fba8367429, createdName=ms7000001909487480, createdTime=Tue Nov 14 13:52:58 CST 2023, time=2023-11-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2193985, encodeId=ad53219398535, content=审稿速度:24.0 | 投稿命中率:50.0 经验分享：慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=15626507481, createdName=ms5000002039979243, createdTime=Tue Mar 19 06:01:55 CST 2024, time=2024-03-19, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2202286, encodeId=2f792202286ea, content=偏重的研究方向：药理学;心血管 经验分享：请问submit to journal到with editor这一步大家都等了多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Tue May 07 19:50:26 CST 2024, time=2024-05-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2204971, encodeId=3bb322049e1fc, content=偏重的研究方向：中药单体 经验分享：请问换编辑后with editor assessment要多久才能under review，已经十多天了😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07092326647, createdName=1225f99em69(暂无昵称), createdTime=Thu May 16 08:42:57 CST 2024, time=昨天, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2204848, encodeId=10d622048481d, content=偏重的研究方向：中药复方 经验分享：投了一个星期了，还是submitted to journal，这正常吗家人们, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=468e9243712, createdName=ms8000002041881019, createdTime=Wed May 15 16:47:57 CST 2024, time=2024-05-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2198942, encodeId=0763219894231, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：肾脏病;中药复方 经验分享：返修回去一个多月了，还是在邀请审稿人，难受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f22a5486325, createdName=ms8000001467150727, createdTime=Wed Apr 17 12:43:58 CST 2024, time=2024-04-17, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2202273, encodeId=5d2522022e3b9, content=大家submit to journal之后多久会变成with editor啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Tue May 07 19:27:24 CST 2024, time=2024-05-07, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2204597, encodeId=bac4220459ece, content=大家有遇到过一审换编辑的情况吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6b89216027, createdName=ms8000001555903844, createdTime=Tue May 14 10:59:31 CST 2024, time=2024-05-14, status=1, ipAttribution=北京)]

2024-05-14 ms8000001555903844 来自北京

大家有遇到过一审换编辑的情况吗

2 5

展开5条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务